Smart patch could replace finger sticks for hospital insulin dosing
NCT ID NCT07194642
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 29 times
Summary
This study will test whether a continuous glucose monitor (CGM) called Dexcom G7 can safely guide insulin therapy in non-ICU hospital patients with diabetes who are also receiving steroids and specialized nutrition. About 80 oncology and post-transplant patients will be randomly assigned to either CGM-guided insulin or standard hourly finger-stick checks. The goal is to see if CGM keeps blood sugar in a safe range and is convenient for both patients and nurses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexcom G7 continuous glucose monitor
What this could lead to
If successful, this could make insulin management easier and safer for hospitalized patients with diabetes who are not in the ICU.
What could go wrong
This is a small pilot study with only 80 participants, so results may not apply broadly. The device may not be accurate enough in this specific patient group.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.